Needs of pharmacists jeopardised by cost-containment strategies? Newsletter Article 15 February 2013 Pages: 2 - 2
Cancer immunotherapy moves towards phase II testing Gill Higgins Newsletter Article 15 February 2013 Pages: 3 - 4
Pharmacist consultations can improve patients’ health Newsletter Article 15 February 2013 Pages: 7 - 7
Use low-dose filgrastim after autologous PBSC transplantation Newsletter Article 15 February 2013 Pages: 7 - 7
Monoclonal antibody MAD11 prevents myelotoxicity in mice Newsletter Article 15 February 2013 Pages: 8 - 8
Tirofiban: a breakthrough in treating unstable angina Gill Higgins Newsletter Article 15 February 2013 Pages: 9 - 10
Discontinuing anticonvulsants: do EEG findings predict relapse? Newsletter Article 15 February 2013 Pages: 12 - 12
Studies suggest broader indications for amifostine Gill Higgins Newsletter Article 15 February 2013 Pages: 13 - 14
Bromocriptine reduces levodopa consumption in Parkinson’s disease Newsletter Article 15 February 2013 Pages: 14 - 14
First-line antineoplastics in metastatic breast cancer… Newsletter Article 15 February 2013 Pages: 15 - 15
… and anastrozole effective in advanced breast cancer Newsletter Article 15 February 2013 Pages: 15 - 15
Transdermal nicotine beneficial in ulcerative colitis Newsletter Article 15 February 2013 Pages: 16 - 16
Cyclosporin alters pharmacokinetics of teniposide in renal cancer Newsletter Article 15 February 2013 Pages: 19 - 19
Sublingual estradiol achieves high serum concentrations Newsletter Article 15 February 2013 Pages: 20 - 20
Calcium antagonists not associated with increased risk of MI Newsletter Article 15 February 2013 Pages: 20 - 20
HRT and VTE: largest study to date shows 2-fold increased risk Newsletter Article 15 February 2013 Pages: 21 - 21
US FDA approves nelfinavir for adults and children with HIV Newsletter Article 15 February 2013 Pages: 22 - 22